Sources & Key Research — PTSD
PTSD and dissociation • US National Center for PTSD. Dissociative subtype of PTSD. Explains depersonalisation and derealisation. www.ptsd.va.gov
PTSD treatment guidelines • Phoenix Australia. Australian Guidelines for the Prevention and Treatment of Acute Stress Disorder, PTSD and Complex PTSD. www.phoenixaustralia.org
Complex PTSD • World Health Organization (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. www.who.int
MDMA research • Mitchell et al. (2021; 2023). Phase 3 randomised trials. Sponsor-funded studies; limitations include functional unblinding and uncertainty about generalisability and durability. doi.org doi.org
MDMA clinical guidance • Yong et al. (2025). Appropriate use of MDMA-assisted psychotherapy for PTSD. RANZCP-endorsed clinical practice guideline. www.ranzcp.org
Australian access • Therapeutic Goods Administration. Prescribe MDMA or psilocybine (psychiatrists). Restricted Authorised Prescriber access to unapproved medicines. www.tga.gov.au
Ibogaine research • Cherian et al. (2024). Magnesium–ibogaine therapy in veterans with traumatic brain injuries. Nature Medicine. Observational study of 30 male veterans, without a control group. doi.org
Ibogaine cardiac safety • Schep et al. (2016). Ibogaine for treating drug dependence. What is a safe dose? Drug and Alcohol Dependence. doi.org
Somatic therapy research • Brom et al. (2017). Somatic Experiencing for PTSD: a randomised controlled outcome study. Small trial with a waitlist comparison. doi.org
Stanford Medicine (2024). Study summary reporting the one-month symptom reductions. med.stanford.edu
Educational information only. Seek individual advice from a qualified health professional. If you or someone else is in immediate danger in Australia, call 000 or go to the nearest emergency department.
